Status:

UNKNOWN

Vasopressin Versus Norepinephrine for the Management of Shock After Cardiac Surgery

Lead Sponsor:

University of Sao Paulo

Conditions:

Shock

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Vasoplegic syndrome after cardiac surgery is a common complication after cardiac surgery, with negative impact on patient outcomes and hospital costs. Pathogenesis of vasodilatory phenomenon after car...

Eligibility Criteria

Inclusion

  • need vasopressor support

Exclusion

  • younger than 18 years;
  • surgery without cardiopulmonary bypass;
  • emergency procedure;
  • ascending and descending thoracic aortic procedures;
  • left ventricular aneurysm resection; enrollment in another study;
  • pregnancy;
  • neoplasm;
  • Raynaud's phenomenon, systemic sclerosis or vasospastic diathesis;
  • severe hyponatremia (Na\<130mEq/L);
  • acute mesenteric ischemia;
  • acute myocardial infarction;
  • cardiogenic shock; and refusal to consent

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2013

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT01505231

Start Date

January 1 2012

End Date

May 1 2013

Last Update

February 12 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Instituto do Coração

São Paulo, São Paulo, Brazil, 05403-000